Inflammation  	Inflammation  	 NNP	B-NP
and  	and  	 CC	O
repair  	repair  	 NN	B-NP
mechanisms  	mechanisms  	 NNS	I-NP
Although  	Although  	 IN	O
both  	both  	 DT	O
rheumatoid  	rheumatoid  	 JJ	B-NP
arthritis  	arthritis  	 NN	I-NP
( 	( 	 -LRB-	O
RA 	RA 	 NNP	B-NP
)  	)  	 -RRB-	O
and  	and  	 CC	O
ankyosing  	ankyosing  	 JJ	B-NP
spondylitis  	spondylitis  	 NNS	I-NP
( 	( 	 -LRB-	O
AS 	AS 	 NNP	B-NP
)  	)  	 -RRB-	O
belong  	belong  	 VBP	O
to  	to  	 TO	O
the  	the  	 DT	O
group  	group  	 NN	O
of  	of  	 IN	O
chronic  	chronic  	 JJ	B-NP
inflammatory  	inflammatory  	 JJ	I-NP
rheumatic  	rheumatic  	 JJ	I-NP
diseases 	diseases 	 NNS	I-NP
,  	,  	 ,	O
they  	they  	 PRP	O
are  	are  	 VBP	O
quite  	quite  	 RB	O
different  	different  	 JJ	O
regarding  	regarding  	 VBG	B-NP
mechanisms  	mechanisms  	 NNS	I-NP
of  	of  	 IN	I-NP
inflammation  	inflammation  	 NN	I-NP
and  	and  	 CC	O
repair 	repair 	 NN	O
.  	.  	 .	O
While  	While  	 IN	O
RA  	RA  	 NNP	B-NP
is  	is  	 VBZ	O
an  	an  	 DT	O
erosive  	erosive  	 JJ	B-NP
destructive  	destructive  	 JJ	I-NP
disease  	disease  	 NN	I-NP
with  	with  	 IN	O
the  	the  	 DT	O
synovium  	synovium  	 NN	B-NP
as  	as  	 IN	O
the  	the  	 DT	O
primary  	primary  	 JJ	B-NP
site  	site  	 NN	I-NP
of  	of  	 IN	I-NP
inflammation 	inflammation 	 NN	I-NP
,  	,  	 ,	O
the  	the  	 DT	O
immune  	immune  	 JJ	O
response  	response  	 NN	O
in  	in  	 IN	O
AS  	AS  	 NNP	O
takes  	takes  	 VBZ	O
place  	place  	 NN	O
primarily  	primarily  	 RB	O
at  	at  	 IN	O
the  	the  	 DT	O
cartilage 	cartilage 	 FW	B-NP
/ 	/ 	 FW	I-NP
bone  	bone  	 FW	I-NP
interface 	interface 	 FW	I-NP
,  	,  	 ,	O
and  	and  	 CC	O
the  	the  	 DT	O
pathological  	pathological  	 NN	O
but  	but  	 CC	O
also  	also  	 RB	O
the  	the  	 DT	O
clinical  	clinical  	 JJ	B-NP
picture  	picture  	 NN	I-NP
is  	is  	 VBZ	O
determined  	determined  	 VBN	O
by  	by  	 IN	O
an  	an  	 DT	O
until  	until  	 IN	O
not  	not  	 RB	O
yet  	yet  	 RB	O
well  	well  	 RB	O
defined  	defined  	 VBN	B-NP
interaction  	interaction  	 VBN	I-NP
between  	between  	 IN	O
inflammation  	inflammation  	 NN	B-NP
and  	and  	 CC	O
new  	new  	 JJ	O
bone  	bone  	 NN	O
formation 	formation 	 NN	O
.  	.  	 .	O
Most  	Most  	 RBS	O
recently 	recently 	 RB	O
,  	,  	 ,	O
first  	first  	 JJ	O
insights  	insights  	 NNS	O
into  	into  	 IN	O
the  	the  	 DT	O
molecular  	molecular  	 JJ	B-NP
mechanisms  	mechanisms  	 NNS	I-NP
between  	between  	 IN	O
inflammation  	inflammation  	 NN	B-NP
and  	and  	 CC	O
bone  	bone  	 NN	O
destruction  	destruction  	 NN	O
or  	or  	 CC	O
new  	new  	 JJ	O
bone  	bone  	 NN	O
formation  	formation  	 NN	O
could  	could  	 MD	O
be  	be  	 VB	O
obtained 	obtained 	 VBN	O
.  	.  	 .	O
Key  	Key  	 JJ	B-NP
molecules  	molecules  	 NNS	I-NP
involved  	involved  	 VBN	O
in  	in  	 IN	O
bone  	bone  	 NN	B-NP
homeostasis  	homeostasis  	 NNS	I-NP
seem  	seem  	 VBP	O
to  	to  	 TO	O
differ  	differ  	 VB	O
between  	between  	 IN	O
RA  	RA  	 NNP	B-NP
and  	and  	 CC	O
AS  	AS  	 NNP	O
patients 	patients 	 NNS	O
.  	.  	 .	O
While  	While  	 IN	O
the  	the  	 DT	O
molecules  	molecules  	 JJ	O
sclerostin  	sclerostin  	 NN	B-NP
and  	and  	 CC	O
dickkopf  	dickkopf  	 CD	B-NP
1 	1 	 CD	O
,  	,  	 ,	O
both  	both  	 DT	O
inhibitors  	inhibitors  	 NN	O
of  	of  	 IN	O
osteoblasts 	osteoblasts 	 NN	B-NP
,  	,  	 ,	O
are  	are  	 VBP	O
elevated  	elevated  	 VBN	O
in  	in  	 IN	O
RA  	RA  	 NNP	B-NP
they  	they  	 PRP	O
are  	are  	 VBP	O
found  	found  	 VBN	O
to  	to  	 TO	O
be  	be  	 VB	O
rather  	rather  	 RB	O
low  	low  	 JJ	O
in  	in  	 IN	O
AS 	AS 	 NNP	O
.  	.  	 .	O
It  	It  	 PRP	O
can  	can  	 MD	O
be  	be  	 VB	O
expected  	expected  	 VBN	O
that  	that  	 IN	O
the  	the  	 DT	O
rapidly  	rapidly  	 RB	O
expanding  	expanding  	 VBG	O
new  	new  	 JJ	O
field  	field  	 NN	O
of  	of  	 IN	O
osteoimmunology  	osteoimmunology  	 NNS	B-NP
will  	will  	 MD	O
help  	help  	 VB	O
to  	to  	 TO	O
clarify  	clarify  	 VB	O
the  	the  	 DT	O
pathogenesis  	pathogenesis  	 NN	B-NP
of  	of  	 IN	O
the  	the  	 DT	O
these  	these  	 DT	O
two  	two  	 CD	O
diseases  	diseases  	 NNS	O
with  	with  	 IN	O
possible  	possible  	 JJ	O
implications  	implications  	 NNS	B-NP
for  	for  	 IN	O
new  	new  	 JJ	O
treatment  	treatment  	 NN	B-NP
targets 	targets 	 NNS	I-NP
.  	.  	 .	O
